You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

SELADELPAR LYSINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for seladelpar lysine and what is the scope of freedom to operate?

Seladelpar lysine is the generic ingredient in one branded drug marketed by Cymabay and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Seladelpar lysine has one hundred and twenty-six patent family members in forty-two countries.

One supplier is listed for this compound.

Summary for SELADELPAR LYSINE
International Patents:126
US Patents:6
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Patent Applications: 14
What excipients (inactive ingredients) are in SELADELPAR LYSINE?SELADELPAR LYSINE excipients list
DailyMed Link:SELADELPAR LYSINE at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for SELADELPAR LYSINE
Generic Entry Date for SELADELPAR LYSINE*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for SELADELPAR LYSINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cymabay LIVDELZI seladelpar lysine CAPSULE;ORAL 217899-001 Aug 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cymabay LIVDELZI seladelpar lysine CAPSULE;ORAL 217899-001 Aug 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Cymabay LIVDELZI seladelpar lysine CAPSULE;ORAL 217899-001 Aug 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cymabay LIVDELZI seladelpar lysine CAPSULE;ORAL 217899-001 Aug 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cymabay LIVDELZI seladelpar lysine CAPSULE;ORAL 217899-001 Aug 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.